Provocative stimulation of growth hormone: A monozygotic twin study discordant for spinal cord injury

Journal of Spinal Cord Medicine

Volumn 30, Issue 5, 2007, Pages 467-472

  Bauman, William A ^a,b   Zhang, Run Lin ^a,b   Spungen, Ann M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Arginine stimulation test; Growth hormone; Insulin like growth factor I; Monozygotic twins; Paraplegia; Spinal cord injuries

Indexed keywords

ARGININE; GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MONOZYGOTIC TWINS; OBESITY; PARAPLEGIA; SPINAL CORD INJURY; ZYGOSITY;

EID: 37049019045     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2007.11754579     Document Type: Article

References (23)

1. Spungen AM, Adkins RH, Stewart CA, et al. Factors influencing body composition in persons with spinal cord injury: A cross-sectional study. J Am Physiol. 2003;95:2398-2407.
2. Spungen AM, Wang J, Pierson RN Jr, Bauman WA. Soft tissue body composition differences in monozygotic twins discordant for immobilization. J Applied Physiol. 2000;88:1310-1315.
3. Bauman WA, Spungen AM, Wang J, Pierson RN, Schwartz E. Relationship of fat mass and serum estradiol with lower extremity bone in persons with chronic spinal cord injury. Am J Physiol. 2006;290:E1098-E1103.
4. Bauman WA, Spungen AM, Flanagan S, Zhong YG, Alexander RL, Tsitouras PD. Blunted growth hormone response to intravenous arginine in subjects with a spinal cord injury. Horm Metab Res. 1994;26:152-156.
5. Shetty K, Sutton CH, Mattson DE, Rudman D. Hyposomatomedinemia in quadriplegic men. Am J Med Sci. 1993;305:95-100.
6. Rao U, Shetty KR, Mattson DE, Rudman IW, Rodman D. Prevalence of low plasma IGF-I in poliomyelitis survivors. J Am Geriatr Soc. 1993;41:697-702.
7. Pierson RN Jr, Wang J, Heymsfield SB, et al. Measuring body fat: calibrating the rulers. Intermethod comparisons in 389 normal Caucasian subjects. Am J Physiol Endocrinol Metab. 1991;261:E103-E108.
8. Wang J, Heymsfield SB, Aulet M, et al. Body fat from body density: underwater weighing vs. dual-photon absorptiometry. Am J Physiol Endocrinol Metab. 1989;256:E829-E834.
9. Daughaday WH. A personal history of the origins of the somatomedin hypothesis and recent challenges to its validity. Perspect Biol Med. 1989;32:194-211.
10. Bauman WA, Spungen AM, Zhong YG, Tsitoruras PD. Chronic baclofen therapy improves the blunted growth hormone response to intravenous arginine in subjects with spinal cord injury. J Clin Endocrinol Metab. 1994;78:1135-1138.
11. Huang TS, Wang YH, Lien IN. Suppression of the hypothalamus-pituitary somatotrope axis in men with spinal cord injuries. Metabolism. 1995;44:1116-1120.
12. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73:1081-1088.
13. Williams T, Berelowitz M, Joffe SN, et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med. 1984;311:1403-1407.
14. Kao PC, Matheny AP Jr, Lang CA. Insulin-like growth factor-I comparisons in healthy twin children. J Clin Endocrinol Metab. 1994;78:310-312.
15. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over age 60 years old. N Engl J Med. 1990;323:1-6.
16. Cuneo RC, Judd S, Wallace JD, et al. The Australian Multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab. 1998;83:107-116.
17. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989;321:1797-1803.
18. Jorgensen JO, Pedersen SA, Thuesen L, et al. Beneficial effects of GH treatment in GH-deficient adults. Lancet. 1989;1:1221-1225.
19. D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin-C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci U S A. 1984;81:935-939.
20. Lee S, Barton ER, Sweeny HL, Farrar RP. Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance trained rats. J Appl Physiol. 2004;96:1097-1104.
21. Dickerman RD, Douglas JA. Bilateral median neuropathy and growth hormone use: a case report. Arch Phys Med Rehabil. 2000;81:1594-1595.
22. Hoffman AR, Strasburger CJ, Zagar A, et al. Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing. J Clin Endocrinol Metab. 2004;89:3224-3233.
23. Bauman WA, Kirshblum SC, Morrison NG, Cirnigliaro CM, Zhang R, Spungen AM. Effect of low-dose baclofen administration on plasma insulin-like growth factor in persons with spinal cord injury. J Clin Pharmacol. 2006;46:476-482.